Independence Trust’s Novo Nordisk NVO Stock Holding History

Independence Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-21,132	Closed	-$568K	–	56
2016 Q2	$568K	Sell	21,132 -2,804	-12%	-$76.9K	0.87%	26
2016 Q1	$648K	Hold	23,936	–	–	1.02%	24
2015 Q4	$695K	Sell	23,936 -230	-1%	-$6.37K	0.9%	25
2015 Q3	$655K	Buy	24,166 +14,896	+161%	+$422K	0.67%	34
2015 Q2	$254K	Hold	9,270	–	–	0.17%	93
2015 Q1	$247K	Buy	+9,270	New	+$213K	0.16%	98
2014 Q4	–	Sell	-9,270	Closed	-$221K	–	141
2014 Q3	$221K	Hold	9,270	–	–	0.15%	90
2014 Q2	$214K	Sell	9,270 -2,240	-19%	-$49.5K	0.14%	98
2014 Q1	$263K	Sell	11,510 -2,500	-18%	-$53.3K	0.18%	82
2013 Q4	$259K	Hold	14,010	–	–	0.18%	84
2013 Q3	$237K	Sell	14,010 -650	-4%	-$10.9K	0.17%	89
2013 Q2	$227K	Buy	+14,660	New	+$244K	0.16%	87

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Independence Trust's NVO Position: Q3 2016 in Review

Independence Trust sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 21,132 shares — an estimated $568K sold.

Independence Trust first reported a position in NVO in Q2 2013 and held it in 12 quarters. The position peaked at $695K in Q4 2015. 513 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

Independence Trust reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
Independence Trust sold 21,132 Novo Nordisk shares in Q3 2016, an estimated $568K.
Independence Trust first reported a position in Novo Nordisk in Q2 2013 and held it in 12 quarters.
Independence Trust's Novo Nordisk position peaked at $695K in Q4 2015.
513 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Independence Trust's 13F filing for Q3 2016, filed 21 Oct 2016.